Blepharospasm Treatment in ScottsdaleInvoluntary Eyelid Closure and Meige Syndrome
Blepharospasm is a neurological condition, not a habit and not an eye disease. Evaluation separates it from the conditions it imitates, and treatment is planned around how much the spasms interfere with daily life.
First-line care is botulinum toxin injection. For selected patients whose spasms remain disabling, eyelid protractor myectomy or selective neurectomy may be considered. Deep brain stimulation and oral medication are managed by neurology, not by Revitalis.
Related case studies
What is Blepharospasm?
Blepharospasm is a form of focal dystonia in which the muscles around the eyes — the orbicularis oculi — contract involuntarily, causing excessive blinking and forced, spasmodic eyelid closure. It is not a problem with the eyes themselves, and it is not a nervous habit that can simply be stopped.
The most common form is benign essential blepharospasm, which usually begins in the fifties or sixties and affects women more often than men. In severe cases the spasms can hold the eyes closed long enough that a person is functionally unable to see, even though vision itself is normal.
Both eyes
Spasm is usually bilateral and roughly symmetric
1st line
Botulinum toxin injection
3–4 mo
Typical duration of an injection cycle
Blepharospasm Signs and Symptoms
- Increased blinking, often set off by bright light, wind, pollution, or stress
- Involuntary, forceful closure of both eyes, usually at the same time
- Eye irritation, light sensitivity, or a gritty, dry-eye sensation
- Difficulty keeping the eyes open while reading, driving, or watching a screen
- A sensory trick — touching the eyelid, humming, or talking may briefly ease the spasm
When It Spreads: Meige Syndrome
When eyelid spasm occurs together with involuntary movement of the jaw, mouth, or tongue, the pattern is called Meige syndrome — a cranial dystonia with oromandibular involvement.
Blepharospasm is often the first symptom, with spread to the lower face developing later. Recognizing Meige syndrome matters because it changes who should be involved in care and which treatments are worth discussing.
What Causes Blepharospasm?
Most blepharospasm is idiopathic, meaning no single identifiable cause is found. It is thought to involve overactivity in deep brain circuits, particularly the basal ganglia and brainstem, rather than a problem in the eyelid muscle itself.
Secondary causes
Less commonly, blepharospasm is secondary to another condition — for example Parkinson disease, Wilson disease, or, rarely, stroke or multiple sclerosis. Unusual features prompt a search for one of these.
Drug-induced blepharospasm
Some cases are drug-induced, most often by certain antipsychotic or anti-nausea medications. A medication review is part of the evaluation, because the plan may change if a drug is contributing.
Conditions That Look Like Blepharospasm
An accurate diagnosis matters because several conditions imitate blepharospasm and are treated differently.
- Hemifacial spasm: twitching on only one side of the face, often caused by a blood vessel pressing on the facial nerve.
- Apraxia of eyelid opening: difficulty reopening the eyes after they close, without visible muscle spasm.
- Dry eye disease: reflex blinking driven by irritation of the ocular surface.
- Tics: brief movements that can be suppressed voluntarily, unlike dystonic spasms.
- Eyelid drooping (ptosis) from myasthenia gravis or another nerve problem.
One-sided spasm points toward hemifacial spasm, and spasm that follows a facial paralysis points toward post-paralytic synkinesis.
When to Seek Prompt Attention
Contact a clinician promptly if eyelid spasm is accompanied by facial weakness or drooping, double vision, a severe headache, difficulty speaking or swallowing, or any sudden neurologic change. These findings may point to a different underlying problem.
Facial drooping together with confusion, imbalance, or arm or leg weakness is a possible stroke. Call 911 rather than waiting for an appointment.
How Blepharospasm Is Diagnosed
Blepharospasm is a clinical diagnosis made by a specialist examination. There is no blood test or scan that confirms it. Evaluation by a neurologist or neuro-ophthalmologist helps confirm the pattern of spasm, screen for secondary or drug-related causes, and rule out the mimics above. Brain imaging or other testing is ordered when features are unusual — spasm on one side only, very young onset, or additional neurologic signs. Coexisting dry eye is assessed at the same time, because ocular surface irritation can both imitate and aggravate the condition.
Blepharospasm Treatment Options
Treatment controls symptoms rather than curing the underlying disorder. Most patients are managed well with injections; surgery is reserved for those whose spasms remain disabling despite them.
1. Botulinum Toxin (First-Line)
Small injections into the muscles around the eyes are the mainstay of care, and botulinum toxin is FDA-approved for blepharospasm associated with dystonia in patients twelve and older. Reported studies describe meaningful relief in roughly 70 to 90 percent of patients, usually beginning within a few days and lasting on average about three to four months, so injections are repeated. Side effects are usually mild and self-limited: a droopy eyelid, blurred or double vision, tearing, or bruising.
2. Supportive and Behavioral Measures
Managing coexisting dry eye, using tinted or FL-41 lenses for light sensitivity, and using sensory tricks may ease symptoms. These measures support treatment; they are not cures, and they do not replace injections when spasms are disabling.
3. Surgery for Refractory Spasm
When injections and medication do not control disabling spasm, eyelid protractor myectomy — surgical removal of part of the spasming muscle — or selective facial neurectomy may be considered. These are individualized options that can reduce symptoms but carry risks and may not provide permanent relief.
4. Facial Neuromuscular Retraining
Facial therapy is part of the broader facial-nerve toolkit and may be discussed alongside injections, particularly when eyelid symptoms sit next to other facial movement problems.
Oral Medication and Deep Brain Stimulation: Neurology-Managed Pathways
Oral medications such as clonazepam, trihexyphenidyl, or baclofen help a minority of patients — around a third in reported experience — and side effects often limit their use, especially in older adults. The supporting evidence is limited. These are prescribed and monitored by a neurologist, not at Revitalis.
For severe, treatment-resistant blepharospasm or Meige syndrome, deep brain stimulation of the globus pallidus internus or the subthalamic nucleus has shown benefit in specialized centers. It remains an emerging, individualized option rather than routine care.
Revitalis does not perform deep brain stimulation and does not manage oral dystonia medication. Both belong with movement-disorder neurology and functional neurosurgery. What we contribute is the facial-nerve examination that confirms the pattern, chemodenervation, and the eyelid and facial-nerve surgery that may be considered when injections stop being enough — together with referral when a neurology-managed pathway is the better fit.
What the Evidence Shows
Blepharospasm is a dystonia, so the goal is symptom control rather than cure. The page stays patient-focused; the studies behind this plan sit in the references below.
- Blepharospasm is a focal dystonia of the muscles that close the eyelids. It is not an eye disease and not a habit, and the spasm is usually present on both sides.
- Benign essential blepharospasm typically begins in the fifties or sixties and affects women more often than men. Severe spasm can leave a person unable to see even though vision is normal.
- Eyelid spasm combined with jaw, mouth, or tongue movement is called Meige syndrome; blepharospasm is often the first symptom, with spread to the lower face later.
- Most cases are idiopathic and involve overactivity in basal ganglia and brainstem circuits. Secondary and drug-induced causes exist and are worth excluding.
- Diagnosis is clinical, made by specialist examination. No single blood test or scan confirms it, and imaging is reserved for unusual features such as one-sided spasm or very young onset.
- Botulinum toxin is first-line and is FDA-approved for blepharospasm associated with dystonia in patients twelve and older. Reported relief is roughly 70 to 90 percent, typically lasting about three to four months, so treatment is repeated.
- Managing dry eye, tinted or FL-41 lenses, and sensory tricks may help symptoms but are not cures.
- Eyelid protractor myectomy or selective neurectomy may be considered for disabling spasm that injections and medication do not control; benefit is individualized and may not be permanent.
- Oral medications help a minority of patients and are often limited by side effects. Deep brain stimulation is an emerging option for severe, treatment-resistant disease and is managed by neurology and functional neurosurgery.
Why Choose Revitalis for Blepharospasm?
Eyelid spasm reaches Revitalis from two directions: patients who have been told it is dry eye and have not improved, and patients who already have a dystonia diagnosis and want injections placed by someone who works on the facial nerve every week. Dr. Nate Jowett is a facial plastic and reconstructive surgeon focused on facial nerve disorders, including the eyelid.
That focus matters most at the two ends of the problem: separating blepharospasm from hemifacial spasm, synkinesis, and apraxia of eyelid opening at the start — and, at the other end, offering eyelid surgery or selective neurectomy when injections alone stop carrying a patient through. Neurology-managed treatment stays with neurology, and we say so directly.
Common questions
Blepharospasm FAQs
Is blepharospasm the same as a tic or dry eye?
No. Blepharospasm is a focal dystonia, meaning the muscles that close the eyelids contract involuntarily. Tics can be briefly suppressed on purpose and dystonic spasms generally cannot, and dry eye causes reflex blinking from surface irritation rather than forced spasmodic closure. Dry eye can sit alongside blepharospasm and make it worse, which is why both are assessed.
What is Meige syndrome?
Meige syndrome is a cranial dystonia in which eyelid spasm occurs together with involuntary movement of the jaw, mouth, or tongue. Blepharospasm is often the first symptom, with spread to the lower face developing later. Recognizing the pattern matters because it changes who should be involved in care and which treatments are worth discussing.
How long does botulinum toxin last for blepharospasm?
Relief usually begins within a few days and lasts on average about three to four months, so most people are re-treated a few times a year. Reported studies describe meaningful relief in roughly 70 to 90 percent of patients, though the degree and duration of benefit vary between individuals.
When is surgery considered for blepharospasm?
Surgery is reserved for disabling spasm that injections and medication do not control. Eyelid protractor myectomy removes part of the spasming muscle, and selective facial neurectomy divides selected nerve branches. Both are individualized options that can reduce symptoms but carry risks and may not provide permanent relief.
Can I go blind from blepharospasm?
Vision itself is not damaged by blepharospasm. In severe cases, though, the spasms can hold the eyes closed long enough that a person cannot see well enough to read, drive, or move about safely until the condition is treated. That functional loss of sight is one of the main reasons to treat it.
Is blepharospasm a sign of a serious brain disease?
Usually not. Most cases are benign essential blepharospasm, an isolated focal dystonia with no identifiable cause. A specialist still screens for secondary causes such as Parkinson disease or Wilson disease and for drug-induced spasm from certain antipsychotic or anti-nausea medications, and orders imaging when features are unusual.
Will blepharospasm go away on its own?
It is typically a chronic condition. Available treatments control symptoms rather than curing the underlying disorder, which is why care is planned as ongoing management with repeated injections and, for selected patients, surgery.
Answers are general and individualized at consultation.
Medical References & Evidence-Based Guidelines
- The pathogenesis of blepharospasm. Zhu L, Meng H, Zhang W, et al. Front Neurol. 2023;14:1336348. PMID: 38274886.
- Development and validation of a clinical guideline for diagnosing blepharospasm. Defazio G, Hallett M, Jinnah HA, et al. Neurology. 2013;81(3):236-40. PMID: 23771487.
- Update on blepharospasm: report from the BEBRF International Workshop. Hallett M, Evinger C, Jankovic J, et al. Neurology. 2008;71(16):1275-82. PMID: 18852443.
- Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update. Ma H, Qu J, Ye L, et al. Front Neurol. 2021;12:630221. PMID: 33854473.
- Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment. Pandey S, Sharma S. J Neurol Sci. 2017;372:162-170. PMID: 28017205.
- Apraxia of eyelid opening and the variable motor phenomenology of blepharospasm. Muroni A, Ferrazzano G, Velucci V, et al. Parkinsonism Relat Disord. 2025;135:107843. PMID: 40300503.
- Developments in the treatment of benign essential blepharospasm. Yen MT. Curr Opin Ophthalmol. 2018;29(5):440-444. PMID: 29916840.
- Globus pallidus internus versus subthalamic nucleus deep brain stimulation for Meige syndrome: a retrospective study on short- and long-term efficacy. Wu G, Weng JC, Liu M, et al. J Neurosurg. 2026;144(5):1084-1094. PMID: 41650451.